AIM float for Cryo-Save Group
Cryo-Save Group, a company which collects and stores adult stem cells for use in stem cell therapy, has raised £26.5 million in its initial public offering (IPO) on AIM. The company’s market capitalisation at the placing price of 210p per share is £101.2 million.
News